LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy.

MLA

Xia, H., et al. “LncRNA MEG3 Promotes the Sensitivity of Vincristine by Inhibiting Autophagy in Lung Cancer Chemotherapy.” European Review for Medical & Pharmacological Sciences, vol. 22, no. 4, Feb. 2018, pp. 1020–27. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=128519999&authtype=sso&custid=ns315887.

APA

Xia, H., Qu, X.-L., Liu, L.-Y., Qian, D.-H., & Jing, H.-Y. (2018). LncRNA MEG3 promotes the sensitivity of vincristine by inhibiting autophagy in lung cancer chemotherapy. European Review for Medical & Pharmacological Sciences, 22(4), 1020–1027.

Chicago

Xia, H., X.-L. Qu, L.-Y. Liu, D.-H. Qian, and H.-Y. Jing. 2018. “LncRNA MEG3 Promotes the Sensitivity of Vincristine by Inhibiting Autophagy in Lung Cancer Chemotherapy.” European Review for Medical & Pharmacological Sciences 22 (4): 1020–27. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edo&AN=128519999&authtype=sso&custid=ns315887.